An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

A M Bolinger(University of California, San Francisco), MJ Cowan(University of California, San Francisco), David V. Glidden(University of California, San Francisco), LJ Risler(Fred Hutch Cancer Center), Bruce Bostrom(Minnesota West Community & Technical College), Kenneth B. DeSantes(University of Wisconsin–Madison), JT Slattery(University of Washington), LOUIS G. HEYN(University of California, San Francisco), AB Zangwill(University of California, San Francisco)
Bone Marrow Transplantation
April 26, 2000
10.1038/sj.bmt.1702371
Cited by 115

Related Papers

Abnormal Brain Development in Newborns with Congenital Heart Disease
|New England Journal of Medicine|2007|851
Patterns of brain injury in term neonatal encephalopathy
|The Journal of Pediatrics|2005|579
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
|Blood|2002|496
Early Brain Injury in Premature Newborns Detected with Magnetic Resonance Imaging is Associated with Adverse Early Neurodevelopmental Outcome
|The Journal of Pediatrics|2005|472
Clinical Neonatal Seizures are Independently Associated with Outcome in Infants at Risk for Hypoxic-Ischemic Brain Injury
|The Journal of Pediatrics|2009|396